Home > Financial Ratios > HESTER BIOSCIENCES

HESTER BIOSCIENCES
Core EBITDA Growth

    Back to All Ratios
HESTER BIOSCIENCES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

HESTER BIOSCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 1.06-2.23-10.800.5218.74

What is the latest Core EBITDA Growth ratio of HESTER BIOSCIENCES ?

The latest Core EBITDA Growth ratio of HESTER BIOSCIENCES is 1.06 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20251.06
Mar2024-2.23
Mar2023-10.80
Mar20220.52
Mar202118.74

How is Core EBITDA Growth of HESTER BIOSCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2025 1.06
Positive
Mar2024 -2.23
Negative
Mar2023 -10.8
Negative
Mar2022 0.52
-97.23
Mar2021 18.74 -

Other Financial Ratios of HESTER BIOSCIENCES


Compare Core EBITDA Growth ratio of peers of HESTER BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HESTER BIOSCIENCES ₹1,198.5 Cr -3.5% -7.8% 1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


HESTER BIOSCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HESTER BIOSCIENCES

-3.5%

-7.8%

1%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses